River Head Capital is the private equity arm of the Sunshine Insurance Group.
River Head Capital was established in January 2015. It is the first batch of insurance private fund pilot units approved by the China Insurance Regulatory Commission. The fund management scale has reached 17 billion yuan.
Adhering to the corporate vision of “making life
better”, with the mission of “creating value, trustworthiness, investing resources in the most valuable companies, and gaining the trust of investors with excellent returns”, the company will actively deploy medical health and emerging Industries, emerging consumption, industrial mergers and acquisitions, real estate and other fields, through entrepreneurial support, strategic investment, financial investment, mergers and acquisitions, corporate restructuring, cross-border investment and other diversified ways to invest in enterprises, comprehensively enhance corporate value and support the healthy and sustainable development of enterprises. At present, River Head Capital has invested in a number of companies in the fields of medical, pharmaceutical, Internet, and innovative financial services.
Industries: Biopharma
Biotechnology
Medical Device
Pharmaceutical
Health Care
Medical
Service Industry
Therapeutics
Beauty
Hospital
E-Learning
Education
Hotel
Communication Hardware
Hardware
Semiconductor
Wearables
Dental
Personal Health
Artificial Intelligence
Machine Learning
Software
Clinical Trials
Automotive
Finance
Financial Services
FinTech
Logistics
Location: Chaoyang, Liaoning, China
